Luis
Pérez de Llano
![Foto de Luis](/img/nophoto.png)
![Foto de McMaster University](/img/noimage_org.png)
McMaster University
Hamilton, CanadáPublications in collaboration with researchers from McMaster University (6)
2022
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research priorities
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 6, pp. 1667-1684
2021
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
-
Exacerbations of severe asthma while on anti–il-5 biologics
Journal of Investigational Allergology and Clinical Immunology, Vol. 30, Núm. 5, pp. 307-316